Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...
CSL has said that with flu jab rates in the US down between 12% and 14% this year, it has decided to delay the planned spinout of its Seqirus vaccines business and cut its profit forecast for the ...
Run untrusted installers in a disposable Windows desktop. Add a simple config to lock it down, then close it to erase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback